Pharma downplays 25% tariff impact: US healthcare could feel the...

Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say

Posted

India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives.

Read Full Article

Please log in to like, share and comment!

Sports

From Erigaisi to Harika: Top 5 Indians to watch at Chennai Grand Masters 2025

The Chennai Grand Masters 2025 is poised to be a significant chess event in Asia, featuring top...

By 0 2

International

In Kuwait? Here’s how to spot fake Airline ticket offers: Top tips from authorities

Kuwaiti travelers are warned about rising airline ticket scams, particularly on social media and...

By 0 5

International

Saudi Arabia raises Saudization goals again, targets now as high as 80% in some sectors

Starting July 27, 2025, Saudi Arabia increases Saudization rates in pharmacy, dentistry, and...

By 0 5

National

Bagmati CM Lama to resign Sunday under conditional agreement

KATHMANDU: Bagmati Province Chief Minister Bahadur Singh Lama has agreed to step down on Sunday...

By 0 14

International

‘Ride of a lifetime’: SpaceX delivers new crew to ISS in record-breaking 15 hours; station population hits 11

SpaceX successfully transported four astronauts to the International Space Station in a...

By 0 19